New FDA Pilot Program To Identify ‘Critical-To-Quality’ Points
This article was originally published in The Gray Sheet
Executive Summary
A “critical-to-quality” pilot program will launch early next year to help hone FDA investigators’ attention on manufacturing processes that are essential to the quality of implantable devices that include batteries.